For lung cancer in particular, treatment[4] typically involves one or more of the following options, alone or in combination: surgery which can cost[5]$15,000or more;chemotherapy, which can cost$10,000 -$200,000or more;radiation therapy, which can cost$10,000-$50,000or more; and/or ...
Apixaban is a cost-effective alternative to warfarin and dabigatran and is dominant over rivaroxaban in AF patients from the perspective of the Portuguese national healthcare system. These conclusions are based on indirect comparisons, but despite this limitation, the information is ...
As seen above,India is one of the most economical destinationsto get cancer treatment abroad. Travel to India for affordable treatments such as: surgery for breast cancer,immunotherapy for lung cancer,Surgery for oral cancer,immunotherapy for prostate cancer ...
City of Hope National Medical Center, Duarte, CA, USA and 3University of California San Diego, San Diego, CA, USA BACKGROUND: Our objective was to analyse the cost effectiveness of computed tomography (CT) screening for lung cancer in terms of the cost per long-term survivor, which has no...
Advances in the treatment of non-small cell lung cancer (NSCLC) can be used to illustrate the impact of different factors on the cost-effectiveness of molecular screening for drug sensitivity biomarkers in oncology. Improved understanding of the biology of NSCLC has led to a number of novel ...
Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non–Small Cell Lung Cancer Key Points Question Is osimertinib, a third-generation tyrosine kinase inhibitor (TKI), a cost-effective first-line therapy for treatment-naive, epidermal growth factor rece...
of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung Cancer Christopher A Lemmon, The Oncologist, 2022 Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in... ...
Gordon Kuntz, Via’s senior director of strategy Gordon Kuntz Clinical pathways were originally created to standardize cancer care and ensure patients receive the best evidence-based treatment for their disease. A divide has developed, however, between pathways that primarily serve physicians and...
The objective of this study was to conduct a cost-effectiveness evaluation of pemetrexed compared to docetaxel in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) for patients with predominantly non-squamous histology in the Spa
Republic of Belarus Singapore Spain Switzerland Thailand Turkey Ukraine Blog Cancer panel - who should test themselves for cancer risk? Laser ablation of brain tumour abroad A modern method of lung cancer treatment - robotic surgery Modern breast implants - everything you need to know about them Ty...